-
![Profile picture of HealthGevity Admin]()
HealthGevity Admin posted in the group Longevity
Vasa Therapeutics secures seed funding to target cardiovascular aging
Biopharma startup sets its sights on age related diseases, including heart failure, peripheral artery disease and sarcopenia.
US-Polish biopharma Vasa Therapeutics has closed a seed funding round, securing $6 million to advance the development of therapies focused on…Read More -
![Profile picture of HealthGevity Admin]()
HealthGevity Admin posted in the group Longevity
How resetting the rhythm might help beat Alzheimer’s
Kate Turley on how realigning circadian rhythms could improve sleep and contribute to the slowing of the progression of dementia.
The circadian rhythm governs many daily functions of living organisms, including sleep-wake cycles, mood, rest-activity patterns, metabolism and hormone b…Read More -
![Profile picture of Naima Hassa (Algeria)]()
Naima Hassa (Algeria) joined the group
![Group logo of Salud y Longevidad en Español]()
Salud y Longevidad en Español![]()
![Profile Photo]()
-
![Profile picture of Naima Hassa (Algeria)]()
Naima Hassa (Algeria) joined the group
![Group logo of Longevity]()
Longevity![Profile Photo]()
-
![Profile picture of Naima Hassa (Algeria)]()
Naima Hassa (Algeria) joined the group
![Group logo of HealthGevity Podcast]()
HealthGevity Podcast![]()
![Profile Photo]()
-
![Profile picture of HealthGevity Admin]()
HealthGevity Admin posted in the group Longevity
Bolden bags new funding to advance neurogenesis-boosting therapeutics
LifeSpan Vision Ventures backs Boston biotech working on treatments that generate new brain cells from existing neural stem cells.
Biotechnology firm Bolden Therapeutics revealed it has secured an undisclosed amount of funding from LifeSpan Vision Ventures to advance…Read More -
![Profile picture of HealthGevity Admin]()
HealthGevity Admin posted in the group Longevity
Gallant raises $15m to advance stem cell therapies for pets
Pet longevity biotech is developing ready-to-use doses of allogeneic stem cell therapeutics targeting chronic diseases in dogs and cats.
Animal health biotech Gallant Therapeutics has secured more than $15 million in Series A financing to advance its “off-the-shelf” stem cell the…Read More -
![Profile picture of HealthGevity Admin]()
HealthGevity Admin posted in the group Longevity
Waging war on chronic inflammation
Halia Therapeutics CEO on moving into multiple Phase 2 trials for chronic inflammation and whether the company may have created a ‘longevity drug.’
Fresh from announcing positive Phase 1 trial results for its inflammation-targeting drug candidate, Utah-based biotech Halia Therapeutics is now pursuing Pha…Read More![]()
-
![Profile picture of HealthGevity Admin]()
HealthGevity Admin posted in the group Longevity
Billionaire-backed Arena BioWorks has aging in its sights
New $500m privately funded institute integrates discovery and company creation as it aims to swiftly translate insights into therapeutics.
Arena BioWorks, a newly launched biomedical research institute, has set its sights on accelerating the translation of basic biological research into…Read More![]()
-
![Profile picture of HealthGevity Admin]()
HealthGevity Admin posted in the group Longevity
‘A vaccine for aging in under ten years’
Agemica founder Ronjon Nag on the moonshot company he believes will develop a vaccine for aging and make a dramatic difference to lifespan and healthspan.
Agemica is on a mission to create a vaccine for aging; its platform uses an AI-driven approach to seek out antiaging therapies that address root cau…Read More![]()
- Load More Posts
